Latest Biotech News

Vertex Pharmaceuticals said it will buy Crinetics Pharmaceuticals in a $10 billion deal, positioning the Boston drugmaker to expand its commercial endocrinology footprint. Under the agreement,...

Novartis is stepping up in antibody-drug conjugates via a $1.1 billion upfront acquisition of Myricx Bio, paying up to $400 million more in milestones. The London-based preclinical ADC specialist...

CMS has published a proposed rule aimed at reducing Medicare outpatient reimbursement for 340B drugs, a move that would effectively restart a policy rejected by the U.S. Supreme Court in...

U.S. GOP lawmakers are pushing for changes to how Trump’s FDA handles clinical trial diversity, arguing that enrollments should better match the demographics of the patients who will use the...

FDA has cleared Visby Medical’s at-home molecular test for flu and COVID-19, marking the first 510(k) clearance for a multi-virus OTC PCR assay. The Visby test differentiates influenza A,...

Mdxhealth disclosed it has received a Nasdaq noncompliance notice after failing to meet the exchange’s minimum $1.00 bid-price requirement. The company said it has fallen below the threshold for...

Arima Genomics said Active Motif will distribute its Hi-C kits for non-formalin-fixed paraffin-embedded research samples, supporting 3D genome studies in areas including epigenetics and gene...

NASA’s Artemis II included astronaut bone marrow housed in organ-chip format, and researchers are now using the material to study how radiation and microgravity affect the body at molecular...

Researchers in Switzerland reported preclinical evidence that chimeric allergen receptor regulatory T cells can suppress birch pollen-driven allergic asthma in mice. In work published in the...

Celea Therapeutics, a PureTech Health spinout, secured $180 million to support a pivotal Phase 3 study of deupirfenidone in idiopathic pulmonary fibrosis. The company plans a head-to-head trial...

Roche moved to deepen its breast cancer pipeline by striking an early-stage deal with Otsuka’s subsidiary Astex, according to reporting on the transaction. The arrangement centers on Astex...

Bristol Myers Squibb disclosed that a confirmatory study for Krazati failed in colorectal cancer, providing an update on the drug’s evidence package. The company said patients taking Krazati in...

FDA clearance has been granted to Visby Medical for an at-home, multi-virus PCR test covering flu and COVID-19, positioning the product as the first such assay cleared via 510(k). Visby’s test...

Celea Therapeutics secured $180 million to fund a pivotal Phase 3 head-to-head study of deupirfenidone in idiopathic pulmonary fibrosis, focusing on an oral small-molecule comparison against...

AbbVie moved to acquire Apogee Therapeutics after years of discussions, setting up a $10.9 billion deal structure described in coverage of the transaction. The report also notes additional...

CMS published details of its proposed 2027 outpatient payment rule that would pair a base rate increase with steep cuts tied to 340B drug payments and changes expanding site-neutral payment...

Novartis agreed to pay $1.1 billion upfront to buy Myricx Bio, aiming to expand its antibody-drug conjugate pipeline with a payload approach described as differentiating from incumbent ADC...

Scribe Therapeutics disclosed plans to pursue an initial public offering after revealing details of its Nasdaq strategy in a Securities and Exchange Commission filing. The company, led by CEO...

Abivax shares rose sharply after updated data provided reassurances for investors following earlier safety-related volatility tied to obefazimod in ulcerative colitis. The stock movement tracked...

United Therapeutics agreed to acquire Thymmune Therapeutics in a $300 million regenerative medicine deal, adding preclinical thymic cell therapy development to its portfolio. Under the terms...